IN THE NEWS
June 19, 2018:
Fortress Biotech Announces Publication of Phase 1 Data on CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia in Biology of Blood and Marrow Transplantation
Avenue Therapeutics to Participate in JMP Securities Life Sciences Conference
June 18, 2018:
Caelum Biosciences Announces Presentation of Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis at American Society of Echocardiography 29th Annual Scientific Sessions
June 6, 2018:
Avenue Therapeutics to Host Key Opinion Leader Call on Intravenous (IV) Tramadol for the Management of Postoperative Pain
June 4, 2018:
Checkpoint Therapeutics to Participate in June Investor Conferences
May 31, 2018:
Mustang Bio to Present at June Investor Conferences
QUICK LINKS
PIPELINE
